From PhD in Melbourne to postdoc in New York
New York-based, Aussie researcher Matt Witkowski has his sights set on improving the effectiveness of CAR T-cell therapy.
- Acute lymphoblastic leukaemia
- Research
Category: Research
Research aims to improve QOL by decreasing treatment toxicity
Kate Vandyke is leading exciting research examining whether a new inhibitor can be used to prepare myeloma patients for therapies and increase their efficacy.
- Myeloma
- Research
Expert Series: AProf. David Ross on how clinical trials are critical to finding curative therapies for MPN
Professor David Ross discusses the "massive explosion" of recent clinical trial activity in MPN.
- Clinical trials
- Interviews with experts
- Myeloproliferative neoplasms
- Research
Improving outcomes for Australians with an MPN 
Dr Liesl Butler is investigating the gene mutations and biological pathways that lead to the development of MPN.
- Myeloproliferative neoplasms
- Research
Q&A: Dr Peter Diamond – our head of research
Head of the Leukaemia Foundation’s National Research Program, Dr Peter Diamond discusses his role, priorities for the program, and exciting breakthroughs coming up in blood cancer research.Â
- Research
Searching for “more effective and gentler” therapies for AML
The Professor of Harvard University’s Department of Stem Cell and Regenerative Biology spoke with us about why he chose this line of work, and his research objectives.
- Acute myeloid leukaemia
- Research
 Adding the microenvironment to the AML therapy mix improves efficacy   
Associate Professor Ingrid Wrinkler's findings have "opened up a whole new field".
- Acute myeloid leukaemia
- Research
Leukaemia Foundation invests almost $3m in innovative AML research
Seven research projects that are part of the National Research Program focus on better understanding and treating acute myeloid leukaemia (AML). 
- Acute myeloid leukaemia
- Research
Understanding MDS and the biological processes driving treatment response
Dr Steven Lane hopes to understand how myelodysplasia (MDS) forms from normal cells.
- Myelodysplastic syndromes
- Research
What’s CAR T-cell therapy?
Dr Bruce Levine explains how it works and why.
- Research
- Treatments and side-effects
